- Oops!Something went wrong.Please try again later.
DGAP-News: Datametrex AI Limited / Key word(s): Product Launch
Toronto, Canada, October 27, 2021 - Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that its wholly-owned subsidiary, Medi-Call MD Inc. ("Medi-Call") has officially launched its MediCall Health App Beta test on Apple devices.
As previously announced in the October 20, 2021 news release, the MediCall Health App was launched for Android smartphones, and has now been added to Apple devices and is downloadable by select beta test users.
The app provides accessible healthcare to people who live in rural or isolated communities and make services more readily available and convenient for people with limited time, mobility, or transportation choices.
The MediCall App is a subscription service that connects patients with doctors, providing technology-driven e-health care services including telehealth, live medical visits and prescriptions. Patients download the app and sign up by entering past medical history, current symptoms and a designated pharmacy where the patient can pick up prescriptions.
"With millions of smartphone users in Canada, the MediCall App can reach patients outside of doctor offices and emergency rooms and is an essential tool for solving problems facing the increased demand on healthcare systems. Datametrex is committed to making digital healthcare a mainstream activity," stated Marshall Gunter, CEO of Datametrex.
About Medi-Call MD
Medi-Call is an enhanced telemedicine company providing technology-driven e-health or m-health care services including prescriptions, launching initially in British Columbia, and then expanding across Canada. The objectives of Medi-Call, include making health care accessible to people who live in rural or isolated communities and making services more readily available or convenient for people with limited time, mobility, or transportation choices. Medi-Call is driven to improve coordination and communication of treatment among members of a health care team and its patients.
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.
For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.
27.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.